(Press-News.org) Hercules, CA -- July 28, 2015 -- Droplet Digital PCR (ddPCR™) has been shown to be a useful tool for the identification of microRNAs (miRNA) circulating in the blood that could serve as potential cancer biomarkers. A study in the journal Oncotarget further supports these findings and identifies a novel miRNA that shows great potential for breast cancer diagnosis. These findings confirm the potential clinical utility of ddPCR technology to precisely and reliably quantify cell-free miRNAs. The study also emphasizes that sample type as well as its preparation are critical in such evaluations.
Using Bio-Rad's QX200™ Droplet Digital PCR (ddPCR) System, the researchers determined absolute levels of key miRNA molecules in plasma and serum samples of patients with a variety of cancers. By comparing data from cancer patients with those of healthy individuals, the team confirmed the potential of miR-181a-5p -- one of nearly 2,000 known human miRNAs -- as a possible diagnostic breast cancer biomarker.
"We demonstrated that Droplet Digital PCR can be successfully used for the detection of circulating miRNA cancer biomarkers that are associated with many different cancer types," said Dr. Manuela Ferracin of the Department of Morphology, Surgery and Experimental Medicine at the University of Ferrara, a member of the Massimo Negrini research group and first author on the paper. "It is a terrific approach for validation and correct quantification of any single selected microRNA of interest," she added.
Droplet Digital PCR Simplifies miRNA Detection
Droplet Digital PCR offers many advantages over qPCR, the traditional analytical method for measuring miRNA in blood, including removing the need for a standard curve and enhancing robustness because digital PCR is less susceptible to variations in PCR efficiency across samples and assays.
Negrini's group previously showed that ddPCR technology coupled with EvaGreen chemistry could accurately and economically quantify cell-free miRNAs. Ferracin pursued the EvaGreen method in her Oncotarget paper by quantifying miRNAs in multiple common cancers. Ferracin used microarrays and small RNA sequencing to screen 80 plasma samples from individuals with breast cancer, colorectal cancer, lung cancer, melanoma, and thyroid cancer, as well as healthy patients. After identifying the most abundant differentially expressed cell-free miRNAs, the group selected nine different miRNAs to quantify using ddPCR technology.
Discovery of a Novel miRNA Breast Cancer Biomarker
Multiple miRNAs showed significant up or downregulation in cancer patients; these miRNAs include miR-181a-5p, which had previously been identified as a candidate biomarker for breast cancer. Negrini's group observed significant downregulation of this miRNA in the serum, but not in plasma, of individuals with breast cancer. This suggests that this miRNA could serve as a powerful diagnostic tool and highlights the importance of sample type.
The group further validated their results with a larger group of breast cancer patients by analyzing serum from two independent cohorts of breast cancer patients: one from the U.S. and a second from Italy. Data from this study confirmed the initial results, showing significant reduction in miR-181a-5p concentrations in the serum of both cohorts (Italy: p < 0.05, U.S.: p < 0.005). The study correctly identified nearly 70% of breast cancer patients with an overall 70% specificity (AUC 0.665 and 0.73, for Italian and U.S. ROC curves, respectively).
"This miRNA therefore has the potential to become a disease biomarker, although further validation (more samples from multiple institutions) is required," Dr. Ferracin said.
Droplet Digital PCR emerged as Dr. Ferracin's technique of choice after more than one year of scrutinizing her methods, because ddPCR technology lets her control variables and quantify miRNA better than any other technique.
INFORMATION:
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs more than 7,600 people worldwide and had revenues exceeding $2.1 billion in 2014. For more information, please visit http://www.bio-rad.com.
ANN ARBOR--Secondary students found healthier foods on more lunch menus in 2013 than in 2011, resulting in fewer nutrition disparities for small schools or those with racially diverse student bodies.
The findings by University of Michigan researchers show significant improvements made in the National School Lunch Program at public middle and high schools in 2013 after many years of meal disparities based on school size or demographics.
"While these improvements are encouraging, continued progress is needed," said Yvonne Terry-McElrath, a researcher at the U-M Institute ...
Wild chimpanzees in the forests of Uganda are increasingly eating clay to supplement the minerals in their diet, according to a long-term international study published in the early version of the journal PLOS ONE. The paper led by the University of Oxford describes how the researchers observed wild chimpanzees in the Budongo forest eating and drinking from clay pits and termite mounds. The paper concludes that this change in diet may be partly due to the widespread destruction of raffia palm trees that chimps relied on for their minerals in the past. However, the main reason ...
(SACRAMENTO, Calif.) -- UC Davis health economists have for the first time projected the total costs of caring for all people with autism spectrum disorder (ASD) in the U.S. for the current calendar year and in 10 years if effective interventions and preventive treatments for the condition are not identified and widely available.
Their forecasts for ASD-related medical, nonmedical and productivity losses are $268 billion for 2015 and $461 billion for 2025. The researchers noted that these estimates are conservative and, if ASD prevalence continues to increase as it has ...
The continuous quality improvement (CQI) approach was introduced on a pilot basis to 30 sites across Uganda. This approach identified barriers in achieving national standards for voluntary medical male circumcision (VMMC), identified possible solutions to overcome these barriers, and carried out improvement plans to test these changes while collecting performance data to objectively measure whether they had bridged gaps.
Teams used a 53-indicator quality assessment tool adapted by the Ministry of Health and based on the WHO VMMC Quality Toolkit as a management tool to ...
Surgeons at The Children's Hospital of Philadelphia (CHOP) joined with colleagues from Penn Medicine recently to complete the world's first bilateral hand transplant on a child. Earlier this month, the surgical team successfully transplanted donor hands and forearms onto eight-year-old Zion Harvey who, several years earlier, had undergone amputation of his hands and feet and a kidney transplant following a serious infection.
Led by L. Scott Levin, M.D., FACS*, Chairman of the Department of Orthopaedic Surgery at Penn Medicine, Director of the Hand Transplantation Program ...
Whether online auctions are selling rare Pokemon cards or fine art, the science behind inciting the highest bids gets a boost from a paper to be published in the September issue of the Journal of Retailing. Researchers from Germany and Australia teamed up to explore how bidders' emotions are affected by different types of auctions and how those emotions affect their bidding.
In "Auction Fever! How Time Pressure and Social Competition Affect Bidders' Arousal and Bids in Retail Auctions," the three authors - Marc T.P. Adam of the University of Newcastle, Professor ...
PHILADELPHIA - Whether you're a human, a mouse, or even a fruitfly, losing sleep is a bad thing, leading to physiological effects and behavioral changes. One example that has been studied for many years is a link between sleep loss and aggression. But it can be difficult to distinguish sleep loss effects from stress responses, especially in rodent or human models.
A team of researchers from the Perelman School of Medicine at the University of Pennsylvania used fruitflies to probe deeper into the cellular and molecular mechanisms that govern aggression and sleep. They ...
Pharmaceutical firms "underinvest" in long-term research to develop new cancer-fighting drugs due to the greater time and cost required to conduct such research, according to a newly published study co-authored by MIT economists.
Specifically, drugs to treat late-stage cancers are less costly to develop than drugs for earlier-stage cancers, partly because the late-stage drugs extend people's lives for shorter durations of time. This means that the clinical trials for such drugs get wrapped up more quickly, too -- and provide drug manufacturers more time to control patented ...
Just as the brain forms memories of familiar faces, the immune system remembers pathogens it has encountered in the past. T cells with these memories circulate in the blood stream looking for sites of new infection.
Recently, however, researchers have shown that memory T cells specific to viral infections can also set up residence in particular tissues. There, they stand guard, ready to respond quickly to the first sign of reinfection.
Now, research led by a team from the University of Pennsylvania School of Veterinary Medicine shows that these resident memory T cells ...
July 28, 2015 - Eyes with central vision loss adapt by developing a new fixation point in a different part of the retina, called the preferred retinal location (PRL). Now for the first time, a new method makes it possible to identify PRLs in both eyes simultaneously, reports a study in the August issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.
The new eye-tracker technique may help in developing visual rehabilitation approaches to improve binocular vision for the many older adults ...
